Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science
Reference39 articles.
1. Hani U, Rahamathulla M, Osmani RA, et al. Recent advances in novel drug delivery systems and approaches for management of breast cancer: A comprehensive review. J Drug Deliv Sci Technol. 2020;56:101505. https://doi.org/10.1016/j.jddst.2020.101505.
2. World Cancer Research Fund International Breast cancer statistics. 2014 cited; Available from. https://www.wcrf.org/int/cancer-facts-figures/data-specificcancers/breast-cancer-statistics.
3. Ferlay J, Soerjomataram I, Dikshit. R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Canc. 2015;5:136. https://doi.org/10.1002/ijc.29210.
4. US Food and Drug Administration (2018). Drug Approval Database. Available online at: https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm567259.htm.
5. Burstein HJ, Sun Y, Dirix LY, Jiang Z, Paridaens R, Tan AR. et al. Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer. J Clin Oncol. 2010;28:1301–7. https://doi.org/10.1200/JCO.2009.25.8707.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献